For the first time, the French National Health Authority (HAS) has issued a clear stance on autism treatment, declaring that psychoanalysis is not recommended due to its lack of sufficient evidence. This statement arises from ongoing debates involving family associations and mental health professionals about how to best approach autism care. The HAS's decisions are influential in shaping health policies in France and signal a significant evolution in the understanding and treatment of autism.

This new position has been eagerly anticipated by families and health professionals alike, particularly as the HAS had not published significant guidance on autism since 2012. The recommendation underscores the authority's commitment to basing treatment methods on solid, evidence-based practices. By addressing the issue, the HAS aims to provide clarity to families and practitioners navigating the complex landscape of autism interventions.

The implications of the HAS's announcement are broad, given that autism affects between 1% and 2% of the population and presents a wide range of challenges including social relationship comprehension and obsessive behaviors. This new guideline will likely steer future treatment modalities away from psychoanalysis and towards approaches supported by evidence, affecting both professionals and families seeking effective strategies for autism management.